NTRB (Nutriband) Cyclically Adjusted Revenue per Share: $0.20 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NTRB Nutriband Inc NTRB
59 GF Score
Price $2.98
GF Value $3.22
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Nutriband Cyclically Adjusted Revenue per Share?

Nutriband NTRB +1.71% 59 Cyclically Adjusted Revenue per Share is $0.20 as of Apr. 2026. GuruFocus rates NTRB with a GF Score™ of 59/100 and a GF Value™ of $3.22 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Nutriband's adjusted revenue per share for the three months ended in Apr. 2026 was $0.036. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.20 for the trailing ten years ended in Apr. 2026.

During the past 12 months, Nutriband's average Cyclically Adjusted Revenue Growth Rate was 5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-26), Nutriband's current stock price is $2.98. Nutriband's Cyclically Adjusted Revenue per Share for the quarter that ended in Apr. 2026 was $0.20. Nutriband's Cyclically Adjusted PS Ratio of today is 14.90.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Nutriband was 52.16. The lowest was 14.50. And the median was 24.00.


Nutriband  (NAS:NTRB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Nutriband's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2.98/0.20
=14.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Nutriband was 52.16. The lowest was 14.50. And the median was 24.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Nutriband Cyclically Adjusted Revenue per Share Related Terms


Nutriband Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Nutriband's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutriband Cyclically Adjusted Revenue per Share Chart

Nutriband Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.19

Nutriband Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.20 0.20 0.19 0.20

NTRB vs INMB, GRCE, ALGS: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Nutriband's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutriband Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nutriband's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Nutriband's Cyclically Adjusted PS Ratio falls into.


NTRB
59GF Score
Nutriband Inc NTRB
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nutriband Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nutriband's adjusted Revenue per Share data for the three months ended in Apr. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Apr. 2026 (Change)*Current CPI (Apr. 2026)
=0.036/333.0200*333.0200
=0.036

Current CPI (Apr. 2026) = 333.0200.

Nutriband Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201607 0.000 240.628 0.000
201610 0.000 241.729 0.000
201701 0.000 242.839 0.000
201704 0.000 244.524 0.000
201707 0.000 244.786 0.000
201710 0.000 246.663 0.000
201801 0.000 247.867 0.000
201804 0.000 250.546 0.000
201807 0.000 252.006 0.000
201810 0.026 252.885 0.034
201901 0.013 251.712 0.017
201904 0.031 255.548 0.040
201907 0.012 256.571 0.016
201910 0.013 257.346 0.017
202001 0.003 257.971 0.004
202004 0.019 256.389 0.025
202007 0.013 259.101 0.017
202010 0.061 260.388 0.078
202101 0.045 261.582 0.057
202104 0.059 267.054 0.074
202107 0.025 273.003 0.030
202110 0.037 276.589 0.045
202201 0.057 281.148 0.068
202204 0.052 289.109 0.060
202207 0.054 296.276 0.061
202210 0.079 298.012 0.088
202301 0.067 299.170 0.075
202304 0.061 303.363 0.067
202307 0.084 305.691 0.092
202310 0.055 307.671 0.060
202401 0.063 308.417 0.068
202404 0.045 313.548 0.048
202407 0.040 314.540 0.042
202410 0.058 315.664 0.061
202501 0.058 317.671 0.061
202504 0.060 320.795 0.062
202507 0.055 323.048 0.057
202510 0.029 0.000
202601 0.033 325.252 0.034
202604 0.036 333.020 0.036

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.20 mean?
Nutriband (NTRB) has a Cyclically Adjusted Revenue per Share of $0.20 as of Apr. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Nutriband and its competitors.
Is Nutriband's Cyclically Adjusted Revenue per Share too high?
Nutriband's current Cyclically Adjusted Revenue per Share is $0.20. Overall, Nutriband has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nutriband's Cyclically Adjusted Revenue per Share compare to INMB and GRCE?
Nutriband's Cyclically Adjusted Revenue per Share of $0.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Nutriband and its competitors. Nutriband's current Cyclically Adjusted Revenue per Share is $0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutriband stock overvalued right now?
Based on GuruFocus' analysis, Nutriband (NTRB) is currently considered Fairly Valued. The stock's GF Value™ is $3.22, compared to a current price of $2.98 — trading 7.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.20. Nutriband's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Nutriband (NTRB), the current Cyclically Adjusted Revenue per Share is $0.20 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutriband (NTRB) Overvalued in 2026?

Based on GuruFocus' analysis, Nutriband stock appears to be undervalued. The current stock price of $2.98 is trading 7.5% below its estimated GF Value™ of $3.22. GuruFocus considers Nutriband to be Fairly Valued.

Key valuation signals for NTRB:

  • Cyclically Adjusted Revenue per Share: $0.20
  • GF Value™: $3.22 vs. price of $2.98 (7.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the NTRB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nutriband Business Description

Address 121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
59GF Score

Get the complete analysis for NTRB

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.98
Price
$3.22
GF Value